Healthy Extracts (HYEX) Net Cash Flow Growth (1y) (2016 - 2025)
Healthy Extracts (HYEX) Net Cash Flow Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | -1,020.00% |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -465.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -465.96% |
| Sep 30, 2025 | 76.91% |
| Jun 30, 2025 | 34.11% |
| Mar 31, 2025 | -90.01% |
| Dec 31, 2024 | 143.11% |
| Sep 30, 2024 | -3.73% |
| Jun 30, 2024 | 150.47% |
| Mar 31, 2024 | -54.00% |
| Dec 31, 2023 | -227.34% |
| Sep 30, 2023 | 46.08% |
| Jun 30, 2023 | -279.84% |
| Mar 31, 2023 | 213.67% |
| Dec 31, 2022 | -107.70% |
| Sep 30, 2022 | 50.22% |
| Jun 30, 2022 | 24.28% |
| Mar 31, 2022 | -174.72% |
| Dec 31, 2021 | 133.40% |
| Sep 30, 2021 | 39.65% |
| Jun 30, 2021 | -91.33% |
| Mar 31, 2021 | 364.08% |